The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Management of Cocaine Abuse and Dependence
Abstract
During the 20th century, there have been recurrent episodes of cocaine abuse in the United States that have achieved epidemic proportions.1 Although the total number of people using the drug has decreased in the past decade, cocaine-related biomedical and psychosocial problems remain a major public health problem in the United States and many other countries. The expanding list of cocaine-related toxic effects, acute and chronic, includes reproductive dysfunction, hepatic necrosis, and pulmonary disease.2 Abuse of and dependence on cocaine may also be associated with disorders of sexual function, sleep, anxiety, and mood, as well as with delirium and psychotic disorders. . . .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Persistent postwithdrawal disorders have been described with different classes of CNS drugs (e.g.protracted insomnia for alcohol and benzodiazepine withdrawal [10,36] and major depression/dysphoria for cocaine and amphetamine withdrawal [10,23] ), and even more so with specific drugs (e.g.quetiapine and paroxetine) within a drug class [6,15,16,33] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“We now have increasing evidence for postwithdrawal disorders with SSRI long-term use [6,15,16,26,37] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“Data from controlled trials [15,20,29] , case reports [16] , and online patient reports [26] show that paroxetine is most likely to be associated with new withdrawal symptoms, and fluoxetine the least.”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“According to most studies [1,15,16,20,29] , even with gradual tapering, withdrawal symptoms still occur.”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“Fava et al. [16] conducted a study of gradual SSRI discontinuation in panic disorder and found that 9 of 20 patients (45%) experienced new withdrawal symptoms, and that 3 of the 9 (33%) patients treated with paroxetine had postwithdrawal disorders at 1 year of follow-up, including bipolar spectrum disorder (n = 2) and major depressive disorder (n = 1).”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“They may resemble rebound symptoms being more severe than the original symptoms, but these disorders persist at least 6 weeks in contrast to rebound symptoms and [6,15,16,26,37] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“Persistent postwithdrawal panic disorder [15,38] has been shown to occur following withdrawal of paroxetine, and paroxetine has also been associated with other postwithdrawal disorders [6,15,16] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
An Improved Diagnostic Evaluation Instrument for Substance Abuse Patients
McLellan, A. T., Luborsky, L. B., WOODY, G. E., & Brien, C. P. O. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198001000-00006 · Cited by 3,163
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Naltrexone and Coping Skills Therapy for Alcohol Dependence
O’Malley, S. S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110045007 · Cited by 1,476
[Drug addiction and drug abuse].
Feuerlein, W. (1969) · PubMed · Cited by 1,415
Abstinence Symptomatology and Psychiatric Diagnosis in Cocaine Abusers
Gawin, F. H. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020013003 · Cited by 1,143
The dopamine hypothesis of the reinforcing properties of cocaine
Kuhar, M. J., Ritz, M. C., & Boja, J. W. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90141-g · Cited by 1,005
Gawin, F. H., & Ellinwood, E. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181806 · Cited by 965
Incentives Improve Outcome in Outpatient Behavioral Treatment of Cocaine Dependence
Higgins, S. T. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950070060011 · Cited by 806
Medical Complications of Cocaine Abuse
Cregler, L. L., & Mark, H. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612043152327 · Cited by 791
Duffy, J. C., & Musto, D. F. (1973) · The American Historical Review · doi:10.2307/1854220 · Cited by 743
The pharmacology of cocaine related to its abuse.
Johanson, C. E., & Fischman, M. W. (1989) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00022-5 · Cited by 694
New concepts in cocaine addiction: The dopamine depletion hypothesis
Dackis, C. A., & Gold, M. S. (1985) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(85)90022-3 · Cited by 607
Acute Cardiac Events Temporally Related to Cocaine Abuse
Isner, J. M., Estes, N. A. M., Thompson, P. D., Costanzo-Nordin, M. R., Subramanian, R., Miller, G., Katsas, G. G., Sweeney, K. G., & Sturner, W. Q. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612043152302 · Cited by 598
(1962) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1962.tb27008.x · Cited by 594
Cocaine Use and HIV Infection in Intravenous Drug Users in San Francisco
Chaisson, R. E. (1989) · JAMA · doi:10.1001/jama.1989.03420040099027 · Cited by 578
A Controlled Trial of Buprenorphine Treatment for Opioid Dependence
Johnson, R. E. (1992) · JAMA · doi:10.1001/jama.1992.03480200058024 · Cited by 567
Risk Factors for Human Immunodeficiency Virus Infection in Intravenous Drug Users
Schoenbaum, E. E., Hartel, D. M., Selwyn, P. A., Klein, R. S., Davenny, K., Rogers, M., Feiner, C., & Friedland, G. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909283211306 · Cited by 494
Achieving cocaine abstinence with a behavioral approach
Higgins, S. T., Budney, A. J., Bickel, W. K., Hughes, J. R., Foerg, F. E., & Badger, G. J. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.5.763 · Cited by 491
Modulation of Cocaine Self-Administration in the Rat Through D-3 Dopamine Receptors
Caine, S. B., & Koob, G. F. (1993) · Science · doi:10.1126/science.8099761 · Cited by 454
Desipramine Facilitation of Initial Cocaine Abstinence
Gawin, F. H. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810020019004 · Cited by 361
Woolverton, W. L., & Johnson, K. M. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90063-c · Cited by 355
Psychotherapy and Pharmacotherapy for Ambulatory Cocaine Abusers
Carroll, K. M. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030013002 · Cited by 348
Integrating systematic cue exposure with standard treatment in recovering drug dependent patients
O'Brien, C. P., Childress, A. R., McLellan, T. A., & Ehrman, R. N. (1990) · Addictive Behaviors · doi:10.1016/0306-4603(90)90045-y · Cited by 295
Gawin, F. H. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790200085011 · Cited by 290
Changes in Mood, Craving, and Sleep During Short-term Abstinence Reported by Male Cocaine Addicts
Weddington, W. W. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810210069010 · Cited by 288
Coronary-Artery Vasoconstriction Induced by Cocaine, Cigarette Smoking, or Both
Moliterno, D. J., Willard, J. E., Lange, R. A., Negus, B. H., Boehrer, J. D., Glamann, D. B., Landau, C., Rossen, J. D., Winniford, M. D., & Hillis, L. D. (1994) · New England Journal of Medicine · doi:10.1056/nejm199402173300702 · Cited by 278
The Management of Cocaine-Associated Myocardial Ischemia
Hollander, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511093331907 · Cited by 277
Buprenorphine versus Methadone Maintenance for Opioid Dependence
KOSTEN, T. R., SCHOTTENFELD, R., ZIEDONIS, D., & FALCIONI, J. (1993) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199306000-00004 · Cited by 267
Carroll, K., Rounsaville, B., & Gawin, F. (1991) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999109027549 · Cited by 264
Antibody-Catalyzed Degradation of Cocaine
Landry, D. W., Zhao, K., Yang, G. X. Q., Glickman, M. H., & Georgiadis, T. M. (1993) · Science · doi:10.1126/science.8456315 · Cited by 252
Suppression of psychoactive effects of cocaine by active immunization
Carrera, M. R. A., Ashley, J. A., Parsons, L. H., Wirsching, P., Koob, G. F., & Janda, K. D. (1995) · Nature · doi:10.1038/378727a0 · Cited by 220
RIVIER, C. L., & Vale, W. W. (1987) · Brain Research · doi:10.1016/0006-8993(87)90953-x · Cited by 211
Antagonism of cocaine self-administration by selective dopamine D1 and D2 antagonists
Bergman, J., Kamien, J. B., & Spealman, R. D. (1990) · Behavioural Pharmacology · doi:10.1097/00008877-199000140-00009 · Cited by 204
Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects.
Foltin, R. W., & Fischman, M. W. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24787-5 · Cited by 202
A controlled trial of buprenorphine treatment for opioid dependence
Johnson, R. E. (1992) · JAMA · doi:10.1001/jama.267.20.2750 · Cited by 199
Biologic Concomitants of Alcoholism
Mendelson, J. H. (1970) · New England Journal of Medicine · doi:10.1056/nejm197007022830106 · Cited by 176
Self-citationTennant, F. S. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370010109025 · Cited by 174
Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study
Satel, S. L., Price, L. H., Palumbo, J., McDougle, C. J., Krystal, J. H., Gawin, F. H., Charney, D. S., Heninger, G. R., & Kleber, H. D. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.12.1712 · Cited by 173
A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients
Margolin, A., Kosten, T. R., Avants, S. K., Wilkins, J., Ling, W., Beckson, M., Arndt, I. O., Cornish, J., Ascher, J. A., Li, S.-H., et al. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01198-6 · Cited by 168
Buprenorphine Suppresses Cocaine Self-Administration by Rhesus Monkeys
Mello, N. K., Mendelson, J. H., Bree, M. P., & Lukas, S. E. (1989) · Science · doi:10.1126/science.2772637 · Cited by 165
Self-citationPharmacotherapy for Cocaine-Abusing Methadone-Maintained Patients Using Amantadine or Desipramine
Kosten, T. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110058009 · Cited by 162
Holman, B. L., Pa, C., Mendelson, J. H., TEOH, S. K., Nardin, R. A., Hallgring, E., Hebben, N., & Johnson, K. A. (1991) · PubMed · Cited by 158
Self-citationCocaine use by clients in methadone programs: Significance, scope, and behavioral interventions
Condelli, W. S., Fairbank, J. A., Dennis, M. L., & Rachal, J. V. (1991) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(91)90040-h · Cited by 155
Grabowski, J. G., Rhoades, H. M., Elk, R., Schmitz, J. M., Davis, C., Creson, D., & Kirby, K. C. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199506000-00004 · Cited by 155
Buprenorphine treatment of opioid dependence: A review.
Bickel, W. K., & Amass, L. (1995) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.3.4.477 · Cited by 150
Selemon, L. D., Goldman‐Rakic, P. S., & Tamminga, C. A. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.1.5 · Cited by 150
Cocaine use and HIV infection in intravenous drug users in San Francisco
Chaisson, R. E. (1989) · JAMA · doi:10.1001/jama.261.4.561 · Cited by 147
Cocaethylene: pharmacology, physiology and behavioral effects in humans.
McCance, E. F., Price, L. H., Kosten, T. R., & Jatlow, P. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10557-0 · Cited by 144
Grief: normal and pathological variants
Viederman, M. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.1.1 · Cited by 137
Outpatient Treatment of 'Crack' Cocaine Smoking With Flupenthixol Decanoate
Gawin, F. H. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810040028005 · Cited by 128
Role of opioid antagonists in treating intravenous cocaine abuse
Kosten, T. R., Kleber, H. D., & Morgan, C. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90589-4 · Cited by 126
Methylphenidate Treatment of Cocaine Abusers without Attention Deficit Disorder: A Negative Report
Gawin, F. H., Riordan, C. E., & Kleber, H. D. (1985) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952998509016861 · Cited by 120
Fatal Injuries after Cocaine Use as a Leading Cause of Death among Young Adults in New York City
Marzuk, P. M., Tardiff, K. J., Leon, A. C., Hirsch, C. S., Stajić, M., Portera, L., Hartwell, N., & Iqbal, M. I. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506293322606 · Cited by 120
Schottenfeld, R. S., Pakes, J., Ziedonis, D. M., & Kosten, T. R. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90258-f · Cited by 118
Single-dose bromocriptine reverses cocaine craving
Dackis, C. A., Gold, M. S., Sweeney, D. R., Byron, J. P., & Climko, R. P. (1987) · Psychiatry Research · doi:10.1016/0165-1781(87)90086-2 · Cited by 109
Cocaine Effects on Pulsatile Secretion of Anterior Pituitary, Gonadal, and Adrenal Hormones*
Mendelson, J. H., Mello, N. K., TEOH, S. K., Ellingboe, J., & COCHIN, J. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-6-1256 · Cited by 106
Self-citationMeyer, R. E., & Mirin, S. M. (1979) · Springer eBooks · doi:10.1007/978-1-4684-3426-2 · Cited by 106
Fluoxetine for Cocaine Dependence in Methadone
Batki, S. L., Manfredi, L., Jacob, P., & Jones, R. T. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199308000-00003 · Cited by 105
Neurochemical effects of cocaine following acute and repeated injection
Taylor, D. L., & Ho, B. T. (1977) · Journal of Neuroscience Research · doi:10.1002/jnr.490030203 · Cited by 105
Biologic Concomitants of Alcoholism
Mendelson, J. H., & Mello, N. K. (1979) · New England Journal of Medicine · doi:10.1056/nejm197910253011704 · Cited by 104
Self-citationMolecular Neurobiology of Drug Addiction
Nestler, E. J. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.37 · Cited by 100
Clinical Evaluation of Naltrexone Treatment of Opiate-Dependent Individuals
(1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770270085008 · Cited by 95
Higgins, S. T., Budney, A. J., Bickel, W. K., & Badger, G. J. (1994) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999409084056 · Cited by 89
Neuroimmunomodulation by opiates and other drugs of abuse: relationship to HIV infection and AIDS.
Donahoe, R. M., & Falek, A. (1988) · PubMed · Cited by 89
Mendelson, J. H., TEOH, S. K., Mello, N. K., Ellingboe, J., & Rhoades, E. M. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10378-9 · Cited by 85
Self-citationEffects of cocaine alone and in combination with mazindol in human cocaine abusers.
Preston, K. L., Sullivan, J. T., Berger, P. A., & Bigelow, G. E. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39434-6 · Cited by 75
Applying behavioral concepts and principles to the treatment of cocaine dependence
Higgins, S. T. (1994) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(94)90128-7 · Cited by 74
Pharmacologic Treatments of Cocaine Abuse
Gawin, F. H., & Kleber, H. D. (1986) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30614-2 · Cited by 72
Aids, drugs of abuse and the immune system: A complex immunotoxicological network
Pillai, R. M., Nair, B. S., & WATSON, R. R. (1991) · Archives of Toxicology · doi:10.1007/bf02098025 · Cited by 71
Carbamazepine treatment of cocaine dependence: a placebo-controlled trial
Kranzler, H. R. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01100-d · Cited by 65
Bromocriptine and amantadine in cocaine detoxification
Giannini, A. J., Folts, D. J., Feather, J. N., & Sullivan, B. S. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90182-0 · Cited by 65
Bromocriptine Therapy in Cocaine Withdrawal
Giannini, A. J., Baumgartel, P., & Dimarzio, L. R. (1987) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1987.tb03011.x · Cited by 65
Cocaine Abuse: A Review of Current and Experimental Treatments
Kleber, H. D., & Gawin, F. H. (1984) · PsycEXTRA Dataset · doi:10.1037/e497012006-008 · Cited by 64
Chronic neuropharmacology of cocaine: progress in pharmacotherapy.
Gawin, F. H. (1988) · PubMed · Cited by 63
Double-blind comparison of carbamazepine and placebo for treatment of cocaine dependence
Montoya, I. D., LEVIN, F. R., Fudalac, P. J., & Gorelick, D. A. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01101-4 · Cited by 59
Tennant, F. S. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.147.1.109 · Cited by 59
Amantadine may facilitate detoxification of cocaine addicts
Alterman, A. I., Droba, M., Antelo, R. E., Cornish, J., Sweeney, K. K., Parikh, G. A., & O’Brien, C. P. (1992) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(92)90004-v · Cited by 59
Tr, K., Schumann, B., Wright, D., Mk, C., & Gawin, F. H. (1987) · PubMed · Cited by 56
Use of contingency contracts in specialty clinics for cocaine abuse.
Anker, A. L., & Crowley, T. J. (1982) · PsycEXTRA Dataset · doi:10.1037/e470472004-001 · Cited by 54
CARBAMAZEPINE FOR COCAINE ADDICTION?
Halikas, J. A., Kemp, K., Kuhn, K. L., Carlson, G. A., & Crea, F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91660-7 · Cited by 53
Sarnyai, Z., Mello, N. K., Mendelson, J. H., Erös-Sarnyai, M., & Mercer, G. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12813-9 · Cited by 52
Self-citationBuprenorphine Treatment of Opiate and Cocaine Abuse: Clinical and Preclinical Studies
Mello, N. K., Mendelson, J. H., Lukas, S. E., Gastfriend, D. R., TEOH, S. K., & Holman, L. (1993) · Harvard Review of Psychiatry · doi:10.3109/10673229309017075 · Cited by 52
Self-citationMello, N. K., Mendelson, J. H., Drieze, J. M., & Kelly, M. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12664-5 · Cited by 51
Self-citationCarbamazepine treatment for cocaine dependence
Cornish, J., Maany, I., Fudala, P. J., Neal, S., Poole, S. A., Volpicelli, P., & O’Brien, C. P. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01102-5 · Cited by 48
Cocaine abuse treatment: A review of current strategies
Rawson, R. A., Obert, J. L., McCann, M. J., Castro, F. G., & Ling, W. W. (1991) · Journal of Substance Abuse · doi:10.1016/s0899-3289(10)80026-4 · Cited by 48
Dackis, C. A., & Gold, M. S. (1988) · Psychiatric Annals · doi:10.3928/0048-5713-19880901-09 · Cited by 45
Double-blind evaluation of the effect of acute amantadine on cocaine craving
Gawin, F. H., Morgan, C., Kosten, T. R., & Kleber, H. D. (1989) · Psychopharmacology · doi:10.1007/bf00439458 · Cited by 44
Role of D1 and D2 dopamine receptors in the behavioral effects of cocaine
Spealman, R. D., Bergman, J., Madras, B. K., Kamien, J. B., & Melia, K. F. (1992) · Neurochemistry International · doi:10.1016/0197-0186(92)90228-j · Cited by 40
Acute effects of cocaine on anterior pituitary hormones in male and female rhesus monkeys.
Mello, N. K., Sarnyai, Z., Mendelson, J. H., Drieze, J. M., & Kelly, M. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38401-6 · Cited by 39
Self-citationKolar, A. F., Brown, B. S., Weddington, W. W., Haertzen, C. C., Michaelson, B. S., & Jaffe, J. H. (1992) · International Journal of the Addictions · doi:10.3109/10826089209068770 · Cited by 38
Marlowe, D. B., Husband, S. D., Lamb, R. J., Kirby, K. C., Iguchi, M. Y., & Platt, J. J. (1995) · American Journal on Addictions · doi:10.1111/j.1521-0391.1995.tb00261.x · Cited by 37
Mendelson, J. H., TEOH, S. K., Mello, N. K., & Ellingboe, J. (1992) · PubMed · Cited by 35
Self-citationThe Role of Psychotherapy in the Treatment of Substance-Use Disorders
Najavits, L. M., & Weiss, R. D. (1994) · Harvard Review of Psychiatry · doi:10.3109/10673229409017121 · Cited by 35
Double-blind comparison of desipramine and placebo in withdrawal from cocaine dependence.
Tennant, F. S., & Al, T. (1984) · PubMed · Cited by 34
Current Pharmacotherapies for Cocaine Abuse:
Tutton, C. S., & Crayton, J. W. (1993) · Journal of Addictive Diseases · doi:10.1300/j069v12n02_08 · Cited by 32
A Behavioral Analysis of the Reinforcing Properties of Alcohol and Other Drugs in Man
Mello, N. K. (1983) · Springer eBooks · doi:10.1007/978-1-4613-3518-4_6 · Cited by 31
Self-citationFrequent cocaine users and their use of treatment.
GFROERER, J., & Brodsky, M. D. (1993) · American Journal of Public Health · doi:10.2105/ajph.83.8.1149 · Cited by 28
Acute Interactions of Buprenorphine with Intravenous Cocaine and Morphine
TEOH, S. K., Mendelson, J. H., Mello, N. K., Kuehnle, J. C., Sintavanarong, P., & Rhoades, E. M. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199304000-00002 · Cited by 27
Self-citationChadwick, M. J., Gregory, D. L., & Wendling, G. (1990) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999009001589 · Cited by 25
Psychopharmacological Trials in Cocaine Abuse Treatment
Kleber, H. D., & Gawin, F. H. (1986) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952998609007393 · Cited by 24
Feldman, S., Siegel, R. A., & Conforti, N. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90053-2 · Cited by 23
Evaluation and clinical management of cocaine abusers.
Rb, M. (1988) · PubMed · Cited by 23
1990-1991 Survey of Pharmacotherapies Used in the Treatment of Cocaine Abuse
Halikas, J. A., Nugent, S. M., Crosby, R. D., & Carlson, G. A. (1993) · Journal of Addictive Diseases · doi:10.1300/j069v12n02_09 · Cited by 21
Bromocriptine treatment of cocaine abuse in patients maintained on methadone
Kosten, T. R., Schumann, B., & Wright, D. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.3.381b · Cited by 21
ResearchNote:Bromocriptine in Cocaine Withdrawal-Does It Work?
Teller, D. W., & Devenyi, P. (1988) · International Journal of the Addictions · doi:10.3109/10826088809056194 · Cited by 19
A Placebo-Controlled Trial of L-DOPA/Carbidopa in Early Cocaine Abstinence
Wolfsohn, R., Sanfilipo, M. P., & Augrist, B. (1993) · Neuropsychopharmacology · doi:10.1038/npp.1993.42 · Cited by 18
Spermine interacts with cocaine binding sites on dopamine transporters
Ritz, M. C., Mantione, C. R., & London, E. D. (1994) · Psychopharmacology · doi:10.1007/bf02245443 · Cited by 13
Johanson, C. E. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)98131-l · Cited by 7
Cocaine and Other Drug Interactions: Strategy Considerations
Jones, R. T. (1986) · PsycEXTRA Dataset · doi:10.1037/e496852006-010 · Cited by 5
Cocaine treatment research and clinical perspectives
Tims, F. M. (1993) · Cited by 1
Research works printed but not linked: 22
- Musto DF. The American disease: origins of narcotic control. New Haven, Conn.: Yale University Press, 1973.
- Mendelson JH, Mello NK. Cocaine and other commonly abused drugs. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's principles of internal medicine. 13th ed. New York: McGraw-Hill, 1994:2429-33.
- National Institute on Drug Abuse. Epidemiologic trends in drug abuse. Vol. 1. Highlights and executive summary. Washington, D.C.: Government Printing Office, 1995. (NIH publication no. 95-3988.)
- Johanson CE, 1989, Pharmacol Rev, 41, 3
- Foltin RW, 1991, J Pharmacol Exp Ther, 257, 247
- McCance EF, 1995, J Pharmacol Exp Ther, 274, 215
- Holman BL, 1991, J Nucl Med, 32, 1206
- Gawin FH, 1988, J Clin Psychiatry, 49, 11
- Millman R, 1988, J Clin Psychiatry, 49, 27
- Mendelson JH, 1992, J Pharmacol Exp Ther, 263, 505
- Mello NK, 1990, J Pharmacol Exp Ther, 254, 815
- Mello NK, 1993, J Pharmacol Exp Ther, 266, 804
- Covi L, 1994, Clin Pharmacol Ther, 55, 132
- Kosten TR, 1987, J Clin Psychiatry, 48, 442
- Kuhar MJ, 1993, Pharmacologist, 35, 28
- Kosten TR, 1988, Am J Psychiatry, 145, 381
- Preston KL, 1993, J Pharmacol Exp Ther, 267, 296
- Kreek MJ. Multiple drug abuse patterns and medical consequences. In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987:1597-604.
- Mendelson JH, Albeck J. Naloxone modification of acute alcohol intoxication in humans. In: Proceedings of the 39th Annual Scientific Meeting, Committee on Problems of Drug Dependence, Cambridge, Mass, July 1977. Washington, D.C.: Committee on Problems of Drug Dependence, 1978:572-82.
- Mendelson JH, 1992, Neuropsychopharmacology, 7, 157
- Gastfriend DR, 1993, Am J Addict, 2, 269
- Gastfriend DR, Mendelson JH, Mello NK, et al. Longitudinal dose comparisons of buprenorphine for combined opiate and cocaine dependence. In: Harris LS, ed. Problems of drug dependence, 1995: proceedings of the 57th Annual Scientific Meeting, the Committee on Problems of Drug Dependence, Inc. NIDA research monograph. Washington, D.C.: Government Printing Office (in press).
Cited by
Sorted by citations
Neurobiology of relapse to heroin and cocaine seeking: a review
Shalev, U., Grimm, J. W., & Shaham, Y. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.1.1 · Cited by 880
Arousal and reward: a dichotomy in orexin function
Harris, G. C., & Aston‐Jones, G. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.08.002 · Cited by 567
Management of Drug and Alcohol Withdrawal
Kosten, T. R., & O'Connor, P. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020617 · Cited by 563
Neuroplasticity in the mesolimbic dopamine system and cocaine addiction
Thomas, M. J., Kalivas, P. W., & Shaham, Y. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.77 · Cited by 521
Camí, J., & Farré, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023160 · Cited by 477
Metadata
- Authors
- Mendelson, J. H., & Mello, N. K.
- Affiliations
- Harvard University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1996-04-11
- Volume
- 334
- Issue
- 15
- Pages
- 965-972
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2338649220
- Cited by
- 291
- References
- 112
- Citations by year
- 2024: 4 · 2023: 4 · 2022: 4 · 2021: 3 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 4 · 2016: 8 · 2015: 7 · 2014: 9 · 2013: 20 · 2012: 14
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r18da006116-05)
- National Institute on Drug Abuse (DA 06116, K05DA000064, KO5-DA 00101, KO5 DA 00064, K05DA000101)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Youth, Drugs, and Violence
- Keywords
- cocaine abuse, cocaine dependence, cocaine toxicity, reproductive disorders, liver necrosis, lung disease, sexual dysfunction, sleep disorders, anxiety, mood disorders, delirium, psychosis
- MeSH terms
- Antidepressive Agents, Carbamazepine, Cocaine, Humans, Narcotic Antagonists, Narcotics, Dopamine Agents, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review